Ommaya/VPS + Surgical resection + PEGFILGRASTIM + Vincristine + TOPOTECAN + Cyclophosphamide + Carboplatin + FILGRASTIM + CISPLATIN + Methotrexate for medulloblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Sep 2022: Trial registered, NCT05535166
  2. 20 Dec 2022: Trial started, NCT05535166

The trials

NCT05535166: Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

State
Under way
Phase
Phase 2
People
130 planned
Started
20 Dec 2022
Primary completion
Jul 2035
Arms
Stratum S-1
Results
None posted
  1. 10 Sep 2022: Trial registered
  2. 20 Dec 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.